AOD 9604 (6mg), CJC-1295 No DAC (3mg), Ipamorelin (3mg) (Blend)

The AOD 9604 (6mg), CJC-1295 No DAC (3mg), Ipamorelin (3mg) formulation, a 12mg research blend is designed for in-vitro and in-vivo exploration of potential metabolic, regenerative, and lipolytic (fat-oxidation) pathways. This combination is studied for its potential to influence growth-hormone–related signaling, energy metabolism, and tissue recovery mechanisms when administered through controlled daily subcutaneous protocols.

This product is intended strictly for research purposes only and is not for human or veterinary use.